Study results released on Monday revealed that a personalized mRNA vaccine manufactured by Moderna and Merck has shown promise in reducing the return of melanoma, the deadliest form of skin cancer. The findings were unearthed by researchers who tracked the impact of the vaccine five years after individuals participated in a Phase 2b study. A…
Politics
·
Personalized mRNA vaccine shows promise in reducing melanoma return: Research
CN
CitrixNews Staff
Originally reported by The Hill
Related Articles
Politics
Tina Peters doubles down on debunked election claims hours after release
Former Mesa County, Colo., elections clerk Tina Peters, hours after she was released from prison on Monday, doubled down...
CitrixNews Staff
·
44 minutes ago
Politics
Moderna gets $50M investment for Ebola vaccine candidate
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support devel...
CitrixNews Staff
·
45 minutes ago
Politics
Appeals court rules Hegseth illegally banned active transgender troops, but can bar new recruits
A divided federal appeals court panel ruled Monday that the Trump administration is unconstitutionally expelling troops ...
CitrixNews Staff
·
51 minutes ago
Politics
Oil Prices Jump as Middle East Tensions Build
Some analysts said the main international oil price, which was up 6 percent on Monday, could climb much higher in the co...
CitrixNews Staff
·
54 minutes ago